Four projects involving members of the cluster, winners of the call for research proposals “Recherche Hospitalo-Universitaire en santé” (RHU)
Olivier VÉRAN, French Minister of Health and Solidarity, Frédérique VIDAL, French Minister of Higher Education, Research and Innovation, and Guillaume BOUDY, French Secretary General for Investment, announced the 17 winners of the fifth call for proposals in the area of university-hospital research. Among the winners, funding was awarded to 4 projects involving members of the cluster.
- CONDOR | Project led by the Institut Bergonié (Bordeaux) jointly with Owkin (Nantes)
Funding: € 9 801 144
Precision Medicine and Sarcoma Immunotherapies
- OPERANDI | Project led by AP-HP (Paris) jointly with the Nantes CHU, the CRCINA (Université de Nantes) and the public interest group (GIP) Arronax
Funding: € 8 555 732
Optimisation and improvement of the efficacy of targeted radionuclide therapies in digestive cancers by imagomics
- PRIMUS | Project led by the Rennes CHU jointly with the Nantes CHU and the Université de Nantes
Funding: € 8 271 646
Multiple sclerosis outcome tool
- FAME | Project led by the Université de Paris jointly with the Nantes CHU
Funding: € 9 776 656
Enhance the experience of families of ICU patients
The OPERANDI and PRIMUS projects have been labelled by the Atlanpole Biotherapies cluster.
ABOUT THE CALL FOR RESEARCH PROPOSALS “RECHERCHE HOSPITALO-UNIVERSITAIRE EN SANTÉ” (RHU)
The call for research proposals “Recherche Hospitalo-Universitaire en santé” (RHU), issued under the French Investing in the Future Programme (PIA), run by the French National Research Agency (ANR), aims to support innovative, large-scale research projects in the healthcare sector. Focused on translational health research that seeks to establish a continuum between fundamental and clinical research, RHU projects federate players from the academic, hospital and corporate sectors who are eligible for funding of between € 4 and 10M.
For this fifth round, the international jury reviewed 89 proposals based both on criteria of scientific and innovation quality, and also on their potential in terms of the eventual medical and social-economic benefits. The jury proposed to select and fund 17 projects covering therapeutic areas and a diverse range of medical needs. These 17 projects will receive an exceptional financial aid of € 142M from the French Investing in the Future Programme.
The highly collaborative winning projects federate a total of 150 partners, including 28 Healthcare Institutions. Since 2015, the Investing in the Future Programme has provided funding for 56 RHU projects, representing a financial assistance of some € 447M.